VENTOLIN INJECTION & SOLUTION FOR …
1 DATA SHEET . Ventolin™ Injection Ventolin™ Solution for Intravenous Infusion Salbutamol injection and salbutamol solution for intravenous
Download VENTOLIN INJECTION & SOLUTION FOR …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Immune Globulin Intravenous (Human) 5% …
www.abopharmaceuticals.comSee PRECAUTIONS and DOSAGE AND ADMINISTRATION sections for important information intended to reduce the risk of acute renal failure. Immune Globulin Intravenous (Human), OCTAGAM, should only be administered
5% GLUCOSE INTRAVENOUS INFUSION In AVIVA …
www.baxterhealthcare.com.auGlucose Intravenous Infusion (Aviva bag) Product Information 5% Glucose Intravenous Infusion AVIVA ccsi43020131101( ) 27 May 2014 Page 1 of 9 Baxter Healthcare
INSULINS - Diabetes In Control
www.diabetesincontrol.comINSULINS Insulin products available and defined according to derivation, onset*, peak, and duration** of action. Route of administration is also shown.
The use of variable rate intravenous insulin infusion ...
www.diabetologists-abcd.org.uk3 This guideline is for the use of a variable rate intravenous insulin infusion (VRIII) in adult inpatients with medical conditions and diabetes/hyperglycaemia, who require intravenous administration of insulin to keep their blood
ADULT INSULIN PRESCRIPTION AND BLOOD …
www.diabetologists-abcd.org.ukINTRAVENOUS INSULIN AND BG MONITORING RECORD SHEET When you have checked or changed the insulin infusion rate, initial …
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.novo-pi.com(insulin aspart injection) for subcutaneous or intravenous use Initial U.S. Approval: 2000